Common Long-Term Side Effects of Aspirin
Daily low-dose aspirin (81-325 mg) for cardiovascular prevention raises risks of gastrointestinal (GI) bleeding, ulcers, and perforation, with odds increasing 50-60% after years of use.[1] Long-term data from trials like ASPREE show higher rates of major GI bleeding (3.8 vs. 2.7 events per 1,000 person-years vs. placebo) and all-cause mortality in older adults.[2] It also impairs kidney function over time, potentially worsening chronic kidney disease (CKD), and heightens intracranial hemorrhage risk (about 38% relative increase).[1][3] Hearing loss links appear in some studies, with high doses correlating to 10-20% higher risk after 10+ years.[4]
How Prescribed NSAIDs Stack Up
Prescribed NSAIDs like ibuprofen (up to 2,400 mg/day), naproxen (up to 1,500 mg/day), or diclofenac carry similar GI risks but often higher cardiovascular (CV) hazards. COX-2 selective ones (celecoxib, etoricoxib) reduce GI bleeding by 50% vs. non-selective NSAIDs or aspirin but elevate heart attack and stroke risk by 20-50%, per PRECISION trial data.[5] Non-selective prescribed NSAIDs increase MI risk 18-44% with chronic use, outpacing aspirin's profile.[6] All NSAIDs, including aspirin, slow CKD progression similarly (eGFR decline 1-2 mL/min/year faster), but prescriptions allow higher doses, amplifying renal strain.[7]
| Risk Category | Aspirin (Long-Term Low-Dose) | Prescribed NSAIDs (Non-Selective) | Prescribed COX-2 Selectives |
|---------------|------------------------------|-----------------------------------|-----------------------------|
| GI Bleeding | High (2-4x baseline) [1] | High (similar or higher doses) [3] | Low (50% reduction) [5] |
| CV Events (MI/Stroke) | Moderate (slight increase) [2] | High (18-44% increase) [6] | High (20-50% increase) [5] |
| Renal Damage | Moderate (CKD progression) [7] | Moderate-High [7] | Moderate [7] |
| Other (e.g., Hearing) | Possible loss [4] | Less data, similar COX inhibition | Limited data |
Why Risks Differ by Drug and Patient
Aspirin irreversibly inhibits COX-1/COX-2 at low doses, offering some cardioprotection absent in other NSAIDs, but its acidity boosts GI mucosal damage.[3] Prescribed NSAIDs use higher total COX inhibition for arthritis/pain, worsening CV/renal profiles—naproxen fares best CV-wise among non-selectives.[6] Patient factors dominate: age >65, prior ulcers, or CKD multiply risks 2-10x across all.[1][7] PPI co-prescription cuts GI events 70-90% for any NSAID.[3]
Head-to-Head Trials and Real-World Data
Meta-analyses of 600,000+ patients rank naproxen safest overall; ibuprofen/celecoxib riskier than aspirin for CV events.[6][8] UK primary care data (2M users) show prescribed NSAIDs link to 79% higher GI bleed hospitalization vs. aspirin.[9] Long-term arthritis cohorts report comparable ulcer rates (10-20% over 5 years) without gastroprotection.[3]
When Doctors Switch or Combine Them
Guidelines favor low-dose aspirin for CV prevention over NSAIDs; for pain, start with non-NSAID alternatives (acetaminophen).[10] Prescribed NSAIDs suit short-term use (<2 weeks) or PPI-protected chronic needs. Avoid in high-risk patients—e.g., no NSAID with aspirin increases bleed risk 3-5x.[1]
[1] BMJ 2016: Aspirin GI risks
[2] NEJM ASPREE 2018
[3] NEJM NSAID review 2014
[4] JAMA Intern Med 2010
[5] NEJM PRECISION 2016
[6] Lancet 2017 meta-analysis
[7] Kidney Int 2016
[8] BMJ 2017 CV risks
[9] Lancet Gastro 2020
[10] Ann Intern Med USPSTF 2022